Enanta Pharmaceuticals Inc. (ENTA)
ENTA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$11.52
-6.34% on the day
Market cap
$335.5M
Small cap
Revenue · 2025
$65.3M
-3.4% on 2024
Net income · 2025
-$81.9M
-125.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ENTA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2013 |
| SEC CIK | 0001177648 |
| SEC industry code | Pharmaceutical Preparations |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $65.3M |
| Net income | -$81.9M |
| Operating income | -$85.3M |
| Net margin | -125.4% |
| Operating margin | -130.7% |
| Revenue growth | -3.4% |
| Cash | $37.4M |
| Total assets | $329.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 5.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-07-02 |
| Latest annual report | 10-K | 2025-11-19 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-08-10 |
| Latest proxy | DEFA14A | 2026-01-26 |
Source: SEC EDGAR submissions feed, 832 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -8.6% |
| 1 month | -8.1% |
| 3 months | -14.3% |
| Year to date | -28.3% |
| 1 year | -1.7% |
| From 52-week high | -32.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ARCT | Arcturus Therapeutics Holdings Inc. | $12.03 | -4.60% | $341.9M |
| IRD | Opus Genetics Inc. | $4.24 | -8.62% | $352.8M |
| INDP | Indaptus Therapeutics Inc. | $2.39 | -2.05% | $318.4M |
| EBS | Emergent BioSolutions Inc. | $6.91 | -1.00% | $354.3M |
| CTNM | Contineum Therapeutics Inc. | $8.42 | -1.69% | $316.8M |
| TTRX | Turn Therapeutics Inc. | $10.60 | -4.59% | $315.8M |
| RLMD | Relmada Therapeutics Inc. | $3.36 | -4.27% | $358.4M |
| CYPH | Cypherpunk Technologies Inc. | $2.84 | -2.07% | $306.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier